ES2173966T3 - Composiciones de esteroles a partir de jabon formado de la trituracion de pasta papelera. - Google Patents
Composiciones de esteroles a partir de jabon formado de la trituracion de pasta papelera.Info
- Publication number
- ES2173966T3 ES2173966T3 ES95932593T ES95932593T ES2173966T3 ES 2173966 T3 ES2173966 T3 ES 2173966T3 ES 95932593 T ES95932593 T ES 95932593T ES 95932593 T ES95932593 T ES 95932593T ES 2173966 T3 ES2173966 T3 ES 2173966T3
- Authority
- ES
- Spain
- Prior art keywords
- jabon
- pasta
- sterols
- crushing
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 229930182558 Sterol Natural products 0.000 title 1
- 235000015927 pasta Nutrition 0.000 title 1
- 150000003432 sterols Chemical group 0.000 title 1
- 235000003702 sterols Nutrition 0.000 title 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 abstract 5
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 abstract 3
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 abstract 3
- LGJMUZUPVCAVPU-JFBKYFIKSA-N Sitostanol Natural products O[C@@H]1C[C@H]2[C@@](C)([C@@H]3[C@@H]([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)CC2)CC1 LGJMUZUPVCAVPU-JFBKYFIKSA-N 0.000 abstract 3
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 abstract 3
- 235000000431 campesterol Nutrition 0.000 abstract 3
- 229950005143 sitosterol Drugs 0.000 abstract 3
- LGJMUZUPVCAVPU-HRJGVYIJSA-N stigmastanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]2(C)CC1 LGJMUZUPVCAVPU-HRJGVYIJSA-N 0.000 abstract 3
- 229940076810 beta sitosterol Drugs 0.000 abstract 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 abstract 2
- 108010028554 LDL Cholesterol Proteins 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fats And Perfumes (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Manufacture Of Tobacco Products (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Uso de una composición que reduce el colesterol que comprende beta-sitosterol, campesterol y que comprende además estigmastanol, en la que el campesterol y el estigmastanol juntos comprenden al menos 50% de la concentración de beta-sitosterol y en el que la relación de beta-sitosterol es 1, 0, el campesterol está entre 0, 2 y 0, 4, y el estigmastanol está entre 0, 2 y 0, 5 en la fabricación de un medicamento para uso en un método de reducción de la concentración en plasma de colesterol lipoproteínico de baja densidad.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31494594A | 1994-09-29 | 1994-09-29 | |
| US314945 | 1994-09-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2173966T3 true ES2173966T3 (es) | 2002-11-01 |
| ES2173966T5 ES2173966T5 (es) | 2008-01-16 |
Family
ID=23222178
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES05011507.0T Expired - Lifetime ES2464465T3 (es) | 1994-09-29 | 1995-09-29 | Composiciones de esteroles a partir de jabón de pulpa |
| ES95932593T Expired - Lifetime ES2173966T5 (es) | 1994-09-29 | 1995-09-29 | Composiciones de esteroles a partir de jabon formado de la trituracion de pasta papelera. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES05011507.0T Expired - Lifetime ES2464465T3 (es) | 1994-09-29 | 1995-09-29 | Composiciones de esteroles a partir de jabón de pulpa |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5770749A (es) |
| EP (3) | EP0783514B2 (es) |
| JP (1) | JPH10506394A (es) |
| CN (1) | CN1057768C (es) |
| AT (1) | ATE216395T1 (es) |
| AU (1) | AU3559795A (es) |
| BG (1) | BG64054B1 (es) |
| BR (1) | BR9509119A (es) |
| CA (1) | CA2201328A1 (es) |
| CZ (1) | CZ298622B6 (es) |
| DE (1) | DE69526442T3 (es) |
| DK (2) | DK0783514T4 (es) |
| EE (1) | EE9700073A (es) |
| ES (2) | ES2464465T3 (es) |
| GE (1) | GEP20022657B (es) |
| HU (1) | HUT77522A (es) |
| LT (1) | LT4305B (es) |
| LV (1) | LV11900B (es) |
| MD (1) | MD1721C2 (es) |
| MX (1) | MX9702308A (es) |
| NO (2) | NO310293B1 (es) |
| NZ (1) | NZ293210A (es) |
| PL (1) | PL186441B1 (es) |
| PT (1) | PT783514E (es) |
| RU (1) | RU2165431C2 (es) |
| SK (1) | SK284250B6 (es) |
| TJ (1) | TJ302B (es) |
| WO (1) | WO1996010033A1 (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965449A (en) * | 1996-07-03 | 1999-10-12 | Forbes Medi-Tech, Inc. | Method of assessing risk for cardiovascular disease and other disorders and phytosterol-based compositions useful in preventing and treating cardiovascular disease and other disorders |
| US6139872A (en) * | 1996-08-14 | 2000-10-31 | Henkel Corporation | Method of producing a vitamin product |
| US5985936A (en) * | 1997-12-18 | 1999-11-16 | Forbes Medi-Tech, Inc. | Method of preventing and delaying onset of Alzheimer's disease and composition therefor |
| US5952393A (en) * | 1998-02-12 | 1999-09-14 | Sorkin, Jr.; Harlan Lee | Composition for reducing serum cholesterol levels |
| US6110502A (en) * | 1998-02-19 | 2000-08-29 | Mcneil-Ppc, Inc. | Method for producing water dispersible sterol formulations |
| JP2002517418A (ja) * | 1998-06-05 | 2002-06-18 | フォーブス メディ−テック インコーポレーテッド | 高められた溶解性および分散性を有するフィトステロールおよび／またはフィトスタノ−ルよりなる組成物 |
| AU4891699A (en) | 1998-07-20 | 2000-02-14 | Forbes Medi-Tech Inc. | Compositions comprising phytosterol, phytostanol or mixtures of both and omega-3fatty acids or derivatives thereof and use of the composition in treating or preventing cardiovascular disease and other disorders |
| US6242001B1 (en) | 1998-11-30 | 2001-06-05 | Mcneil-Ppc, Inc. | Method for producing dispersible sterol and stanol compounds |
| DE19916034C1 (de) * | 1999-04-09 | 2000-08-03 | Cognis Deutschland Gmbh | Verfahren zur Gewinnung von Phytosterinen |
| JP2002543095A (ja) * | 1999-04-27 | 2002-12-17 | ステロール テクノロジース エルティディ． | 抽出単離方法 |
| JP2002543088A (ja) * | 1999-04-27 | 2002-12-17 | フォーブス メディ−テック インコーポレーテッド | 木材または植物由来供給源からのフィトステロールの精製方法、およびそれから生じる組成物 |
| US6770767B1 (en) * | 1999-04-27 | 2004-08-03 | Sterol Techologies Ltd. | Method for the extraction and isolation of neutral substances from a soap |
| FI991533L (fi) * | 1999-07-05 | 2001-01-06 | Sohkar Oy | Menetelmä orgaanisten aineiden käsittelemiseksi |
| WO2001015552A1 (en) * | 1999-08-30 | 2001-03-08 | Ocean Nutrition Canada Ltd. | A nutritional supplement for lowering serum triglyceride and cholesterol levels |
| US6998501B1 (en) | 1999-08-30 | 2006-02-14 | Ocean Nutrition Canada Limited | Nutritional supplement for lowering serum triglyceride and cholesterol levels |
| US6197832B1 (en) | 1999-09-14 | 2001-03-06 | Harlan Lee Sorkin, Jr. | Composition for reducing serum cholesterol levels |
| US6355274B1 (en) | 1999-12-15 | 2002-03-12 | Mcneil-Ppc, Inc. | Encapsulated long chain alcohols |
| NZ508692A (en) * | 1999-12-15 | 2002-10-25 | Mcneil Ppc Inc | Cholesterol lowering comestibles comprising policosanol (predominately octasanol) and sterol |
| US7232574B1 (en) | 1999-12-15 | 2007-06-19 | Mcneil-Ppc, Inc. | Long chain alcohols provided in edible oils |
| US7147859B2 (en) * | 2000-05-15 | 2006-12-12 | Laboratorios Biosintetica Ltda. | Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers |
| BR0001794A (pt) * | 2000-05-15 | 2001-12-26 | Laboratorios Biosintetica Ltda | Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares) |
| WO2003009854A1 (en) * | 2001-07-20 | 2003-02-06 | Lonza Ag | Lipid lowering composition comprising carnitine and phytosterol |
| WO2003075931A1 (en) * | 2002-03-14 | 2003-09-18 | Forbes Medi-Tech Inc. | A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| US7368138B2 (en) * | 2002-03-21 | 2008-05-06 | Archer-Daniels-Midland Company | Extraction of phytosterols from corn fiber using green solvents |
| CA2433246A1 (en) * | 2003-06-25 | 2004-12-25 | Telum Technologies Inc. | Process for recovering value-added products from pulping soap |
| WO2007071036A1 (en) * | 2005-12-20 | 2007-06-28 | Forbes Medi-Tech Inc. | Emulsions comprising non-esterified phytosterols in the aqueous phase |
| US8309156B2 (en) * | 2005-12-20 | 2012-11-13 | Pharmachem Laboratories, Inc. | Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high HLB emulsifiers |
| US20070254026A1 (en) * | 2006-05-01 | 2007-11-01 | Forbes Medi-Tech Inc. | Softgel capsules |
| WO2007124597A1 (en) * | 2006-05-01 | 2007-11-08 | Forbes Medi-Tech Inc. | Composition comprising one or more esterified phytosterols and/or phytostanols into which are solubilized one or more unesterified phytosterols and/or phytostanols, in order to achieve therapeutic and formulation benefits |
| EP2036445A1 (en) * | 2007-09-05 | 2009-03-18 | Dietetics Pharma S.r.l. | Nutraceutic preparation in powder form containing free plant sterols |
| US20110207952A1 (en) * | 2010-02-22 | 2011-08-25 | Rafael Avila | Cholesterol extraction from algae and preparation of vegan vitamin d3 |
| EA024619B1 (ru) * | 2014-11-21 | 2016-10-31 | Эльвин Гаджи оглы Керимли | ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ |
| SE540791C2 (en) | 2016-01-29 | 2018-11-13 | Stora Enso Oyj | Extraction of phytosterols |
| WO2017137908A1 (en) | 2016-02-12 | 2017-08-17 | Stora Enso Oyj | Distillation of neutral compounds from tall oil soap |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2573891A (en) * | 1950-05-09 | 1951-11-06 | Pittsburgh Plate Glass Co | Recovery of sterols |
| US2715638A (en) * | 1953-07-28 | 1955-08-16 | American Cyanamid Co | Production of sterols from tall oil pitch |
| US2835682A (en) * | 1955-08-08 | 1958-05-20 | Swift & Co | Sterol recovery process |
| US3840570A (en) * | 1970-12-07 | 1974-10-08 | Procter & Gamble | Process for preparing sterols from tall oil pitch |
| SE417107B (sv) * | 1973-06-29 | 1981-02-23 | Bjarne Holmbom | Forfarande for foredling av sapor |
| US4044031A (en) * | 1976-07-02 | 1977-08-23 | Ake Allan Johansson | Process for the separation of sterols |
| US4208286A (en) † | 1977-11-03 | 1980-06-17 | Kauppi Pekka K | Sulphate soap skimming apparatus |
| US4153622A (en) * | 1978-05-18 | 1979-05-08 | Medipolar Oy | Process for the recovery of β-sitosterol |
| FI58333C (fi) * | 1978-10-27 | 1981-01-12 | Kaukas Ab Oy | Foerfarande foer framstaellning av under 5 vikt-% alfa2-sitosterol innehaollande beta-sitosterolkoncentrat |
| FI57956C (fi) * | 1978-12-12 | 1980-11-10 | Farmos Oy | Foerfarande foer isolering av beta-sitosterol med laog alfa-sitosterolhalt |
| FI59416C (fi) * | 1979-11-19 | 1981-08-10 | Farmos Oy | Foerfarande foer utvinning av beta-sitosterol ur en sterolblandning utvunnen fraon raosaopans neutralfraktion |
| FI63423C (fi) * | 1981-01-27 | 1983-06-10 | Farmos Oy | Foerfarande foer separering av beta-sitosterol fraon en sterolblandning utvunnen ur raosaopans neutralfraktion |
| JPS57206336A (en) * | 1981-06-12 | 1982-12-17 | Ajinomoto Co Inc | Edible oil |
| FI812279A7 (fi) † | 1981-07-21 | 1983-01-22 | Kaukas Ab Oy | Menetelmä sulfaattiselluloosaprosessin raakasuovan neutraliaineesta eristetyn -sitosterolin puhdistamiseksi. |
| FI65440C (fi) * | 1981-07-21 | 1984-05-10 | Kaukas Ab Oy | Foerfarande foer separering av beta-sitosterol med en laog alfa-sitosterolhalt |
| JPS58116415A (ja) * | 1981-12-28 | 1983-07-11 | Riyoushiyoku Kenkyukai | コレステロ−ル低下剤の使用方法 |
| JPS6479119A (en) * | 1987-09-22 | 1989-03-24 | Daiichi Seiyaku Co | Drug of blended two components |
| FR2653974B1 (fr) * | 1989-11-03 | 1992-12-31 | Expanchimie Sarl | Additif alimentaire constitue d'extraits de soja et/ou d'avocat. |
| CA2028759A1 (en) † | 1989-11-22 | 1991-05-23 | Jean-Marie Cassal | Steroids |
| FI964951A0 (fi) * | 1991-05-03 | 1996-12-11 | Raision Tehtaat Oy Ab | Seerumin korkean kolesterolitason alentamiseen käytettävä aine ja sen käyttö |
| US5286845A (en) † | 1992-05-20 | 1994-02-15 | Union Camp Corporation | Acidification of tall oil soap using carbon dioxide |
-
1995
- 1995-09-29 WO PCT/CA1995/000555 patent/WO1996010033A1/en active IP Right Grant
- 1995-09-29 SK SK415-97A patent/SK284250B6/sk unknown
- 1995-09-29 CN CN95196307A patent/CN1057768C/zh not_active Expired - Fee Related
- 1995-09-29 CZ CZ0092797A patent/CZ298622B6/cs not_active IP Right Cessation
- 1995-09-29 JP JP8511228A patent/JPH10506394A/ja not_active Ceased
- 1995-09-29 EE EE9700073A patent/EE9700073A/xx unknown
- 1995-09-29 EP EP95932593A patent/EP0783514B2/en not_active Expired - Lifetime
- 1995-09-29 AT AT95932593T patent/ATE216395T1/de not_active IP Right Cessation
- 1995-09-29 TJ TJ97000458A patent/TJ302B/xx unknown
- 1995-09-29 AU AU35597/95A patent/AU3559795A/en not_active Abandoned
- 1995-09-29 DE DE69526442T patent/DE69526442T3/de not_active Expired - Lifetime
- 1995-09-29 EP EP01118776A patent/EP1148062A3/en not_active Withdrawn
- 1995-09-29 HU HU9702031A patent/HUT77522A/hu unknown
- 1995-09-29 MX MX9702308A patent/MX9702308A/es unknown
- 1995-09-29 MD MD97-0178A patent/MD1721C2/ro unknown
- 1995-09-29 ES ES05011507.0T patent/ES2464465T3/es not_active Expired - Lifetime
- 1995-09-29 DK DK95932593T patent/DK0783514T4/da active
- 1995-09-29 CA CA002201328A patent/CA2201328A1/en not_active Abandoned
- 1995-09-29 PL PL95319384A patent/PL186441B1/pl not_active IP Right Cessation
- 1995-09-29 NZ NZ293210A patent/NZ293210A/xx not_active IP Right Cessation
- 1995-09-29 ES ES95932593T patent/ES2173966T5/es not_active Expired - Lifetime
- 1995-09-29 PT PT95932593T patent/PT783514E/pt unknown
- 1995-09-29 BR BR9509119A patent/BR9509119A/pt not_active IP Right Cessation
- 1995-09-29 RU RU97107020/04A patent/RU2165431C2/ru not_active IP Right Cessation
- 1995-09-29 GE GEAP19953712A patent/GEP20022657B/en unknown
- 1995-09-29 DK DK05011507.0T patent/DK1707572T3/da active
- 1995-09-29 EP EP05011507.0A patent/EP1707572B1/en not_active Expired - Lifetime
-
1996
- 1996-08-30 US US08/706,354 patent/US5770749A/en not_active Expired - Fee Related
-
1997
- 1997-03-20 NO NO19971304A patent/NO310293B1/no not_active IP Right Cessation
- 1997-03-25 BG BG101354A patent/BG64054B1/bg unknown
- 1997-04-23 LT LT97-074A patent/LT4305B/lt not_active IP Right Cessation
- 1997-04-28 LV LVP-97-78A patent/LV11900B/en unknown
-
2001
- 2001-03-01 NO NO20011062A patent/NO322293B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2173966T3 (es) | Composiciones de esteroles a partir de jabon formado de la trituracion de pasta papelera. | |
| Kovanen et al. | Low density lipoprotein receptors in bovine adrenal cortex. I. Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured adrenocortical cells | |
| ATE243498T1 (de) | Aerosol formulierungen für buccale und pulmonale anwendung | |
| CO4970835A1 (es) | Inhibicion de la oxidacion de lipoproteinas | |
| KR970706006A (ko) | 폐 계면활성제와의 배합물 형태로 1종 이상의 글루코코르티코이드를 함유하는 irds 및 ards 치료용 조성물(compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards) | |
| BR9915008A (pt) | Composição de xampu, e, processo para preparação da mesma | |
| BR9917074A (pt) | Composição cosmética ou famacêutica do tipoemulsão óleo-em-água que compreende um agentebiologicamente ativo micronizado e um sistemaemulsionante apropriado e processo detratamento cosmético | |
| DE50011218D1 (de) | Verwendung von nanoskaligen sterolen und sterolestern | |
| BR0203902A (pt) | Composições de compostos bioquìmicos envolvidos no metabolismo bioenergético das células e método de uso da mesma | |
| ATE263578T1 (de) | Feste arzneiformen, enthaltend clathrate vom steroidalen sexualhormon ethinylestradiol | |
| AP2001002054A0 (en) | Use of biogenic estrogen sulfamates for hormone replacement therapy. | |
| FI971536A0 (fi) | Keratinosyytti-kasvutekijän analogeja | |
| Wiegratz et al. | Effect of dienogest-containing oral contraceptives on lipid metabolism | |
| Hofmann et al. | Chenotherapy for gallstone dissolution: II. Induced changes in bile composition and gallstone response | |
| CL2004000026A1 (es) | Uso de una composicion que comprende 0 a alrededor de 29% de cis-clomifeno y de alrededor de 100 a alrededor de 71% de trans-clomifeno para preparar un medicamento util para aumentar los niveles de testosterona en suero en un mamifero masculino. | |
| McCall et al. | Psyllium husk I: effect on plasma lipoproteins, cholesterol metabolism, and atherosclerosis in African green monkeys | |
| Inal et al. | Effects of postmenopausal hormone replacement and α-tocopherol on the lipid profiles and antioxidant status | |
| PT1135193E (pt) | Agentes para o tratamento de tumores a base de lipossomas e compreendendo tamoxifeno | |
| BR9814284A (pt) | Composições e métodos para regulação de fagocitose e expressão de icam-1 | |
| ES2128710T3 (es) | Liposomas que contienen proteinas encapsuladas, procedimiento para su produccion asi como las preparaciones farmaceuticas y cosmeticas que contienen estos liposomas. | |
| Register et al. | Effects of tibolone and conventional hormone replacement therapies on arterial and hepatic cholesterol accumulation and on circulating endothelin-1, vascular cell adhesion molecule-1, and E-selectin in surgically menopausal monkeys | |
| ATE173624T1 (de) | Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten | |
| Erberich et al. | Hormone replacement therapy in postmenopausal women and its effects on plasma lipid levels | |
| KR890701091A (ko) | 프레그네놀론 또는 프레그네놀론 에스테르를 함유하는 수화지질 층판상 또는 리포솜을 기제로 한 조성물 및 이러한 조성물이 들어있고 재생 혹은 생기회복 활성을 갖는 화장제 혹은 제약 조성물, 특히 피부과 조성물 | |
| Leuschner | Ursodeoxycholic acid therapy in primary biliary cirrhosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 783514 Country of ref document: ES |